Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Bortezomib for Injection

Approval Number

国药准字H20243439

Company海南双成药业股份有限公司

Registration Date

April 7, 2024

Drug Information

Generic Name

注射用硼替佐米

Dosage Form

注射剂

Strength

3.5mg

Drug Type

化学药品

Registration Date

April 7, 2024

Company Information

Applicant Company

Company Name海南双成药业股份有限公司

Company Address

海口市秀英区兴国路16号

Manufacturing Company

Company Name宁波双成药业有限公司

Company Address

浙江省宁波市杭州湾新区滨海四路866号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy